This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Join   Fellows' Corner July 27, 2011

Harmful effects of hypothyroidism on maternal and fetal health drive new guidelines for managing thyroid disease in pregnancy
Thyroid    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Emerging data clarifying the risks of insufficient thyroid activity during pregnancy on the health of the mother and fetus, and on the future intellectual development of the child, have led to new clinical guidelines for diagnosing and managing thyroid disease during this critical period. The guidelines, developed by an American Thyroid Association (ATA) expert task force, are presented in Thyroid, a peer-reviewed journal published by Mary Ann Liebert, Inc. and are available free online. More

New guidelines outline diagnosis, management of hyperthyroidism
Endocrine Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The American Association of Clinical Endocrinologists and the American Thyroid Association have collaborated to release new guidelines outlining the appropriate management of patients with hyperthyroidism and other causes of thyrotoxicosis."Our goal with these new guidelines is to provide every doctor treating thyroid patients the tools they need to provide the most effective care," AACE president Yehuda Handelsman, M.D., said in a press release. More

When is the best time to take thyroid hormone?
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hypothyroidism is treated by replacement of thyroid hormone in pill form, specifically levothyroxine. It is well documented that food and a number of medications can decrease the absorption of levothyroxine. This is especially true with calcium and iron pills. Consequently, many patients are instructed to take their levothyroxine on an empty stomach before breakfast and to wait up until an hour before eating. Some patients find this timing inconvenient. A prior study suggested that taking levothyroxine at bedtime was equally as effective in providing stable thyroid hormone levels. The goal of this study was to compare the effect of taking levothyroxine at bedtime as opposed to taking it before breakfast. More

US dietary iodine status remains sufficient overall, but women of child-bearing age may be mildly iodine-deficient
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail
Adequate dietary iodine intake is required for thyroid hormone synthesis. The iodine nutritional status of the U.S. population has been assessed periodically since 1971 by the National Health and Nutritional Examination Survey. The recommended dietary allowances for iodine are 150 µg daily in nonpregnant adults and 220 µg daily in pregnant women. Major sources of iodine in the U.S. diet include iodized salt, dairy foods, and some grain products. More

Modified-release recombinant human TSH and its effect on large goiters treated with radioactive iodine
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail
A thyroid gland that is enlarged for any reason is called a goiter. A goiter can be seen when the thyroid is overactive, underactive or functioning normally. If there are nodules in the goiter it is called a multinodular goiter. Sometimes multinodular goiters get large enough to cause symptoms such as difficult swallowing or choking. When this happens, surgery is often the main option. However, several studies have shown that treatment with radioactive iodine may produce enough shrinking in size of the goiter to improve symptoms. More

Manufacturer recalls one lot of calcium gluconate injection
Endocrine Today    Share    Share on FacebookTwitterShare on LinkedinE-mail
American Regent has initiated a voluntary recall of one lot of calcium gluconate injection, USP, 10 percent, 100 mL - lot #1006 - due to possible silicone particle contamination. Potential adverse events after IV administration of solutions containing particulates may include disruption of blood flow within small blood vessels in the lung, localized inflammation and granuloma formation, according to an FDA press release. More
ATA Thyroid Weekly News Briefs
ATA does not develop, exert any editorial or other control, or guarantee the accuracy, completeness, efficacy, or timeliness, of the materials, information, advertising or promotional activities ("Content") in this publication. Inclusion of Content in this publication does not constitute or imply endorsement, agreement, recommendation, or favoring by ATA of such information or the entities mentioned or promoted herein. Use of any Content appearing or referenced in this publication or obtained from advertisers is voluntary, and reliance on it should only be undertaken after an independent review by qualified experts. ATA is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use of, reference to, reliance on, or performance pursuant to such Content.

Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Julie Bernhard, Content Editor, 469.420.2647   Contribute news
This edition of the ATA Weekly News Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
July 20, 2011
July 13, 2011
July 6, 2011
June 29, 2011

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063